Epiboly, the first morphogenetic cell movement that occurs in the zebrafish embryo, is the process by which the blastoderm thins and spreads to engulf the yolk cell. This process requires the concerted actions of the deep cells, the enveloping layer (EVL) and the extra-embryonic yolk syncytial layer (YSL). The EVL is mechanically coupled to the YSL which acts as an epiboly motor, generating the force necessary to draw the blastoderm towards the vegetal pole though actomyosin flow and contraction of the actomyosin ring. However, it has been proposed that the endocytic removal of yolk cell membrane just ahead of the advancing blastoderm may also play a role. To assess the contribution of yolk cell endocytosis in driving epiboly movements, we used a combination of drug-and dominant-negativebased approaches to inhibit Dynamin, a large GTPase with a well-characterized role in vesicle scission. We show that Dynamin-dependent endocytosis in the yolk cell is dispensable for epiboly of the blastoderm. However, global inhibition of Dynamin function revealed that Dynamin plays a fundamental role within the blastoderm during epiboly, where it maintains epithelial integrity and the transmission of tension across the EVL. The epithelial defects were associated with disrupted tight junctions and a striking reduction of cortically localized phosphorylated ezrin/radixin/moesin (P-ERM), key regulators of epithelial integrity in other systems. Furthermore, we show that Dynamin maintains EVL and promotes epiboly progression by antagonizing Rho A activity.
Introduction
Epiboly, generally defined as the thinning and spreading of one tissue over another, is a widely employed mechanism of morphogenesis that is essential for the development of most animals (Kane and Adams, 2002) . In fish, frogs and worms, epiboly is required for blastopore closure and the successful completion of gastrulation (Betchaku and Trinkaus, 1978; Keller, 1980; Warga and Kimmel, 1990; Williams-Masson et al., 1997) . In addition, in placental animals, it has been proposed that spreading of the trophectoderm during implantation is driven by an epiboly-like process (Kane and Adams, 2002) . Despite the fundamental nature of this mode of morphogenesis, the cellular and molecular underpinnings of epiboly are poorly understood (Lepage and Bruce, 2010) .
Much of what we know regarding the mechanisms driving epiboly, we have learned through the study of teleost development. In teleost fish, such as Fundulus or zebrafish, the blastoderm begins its development on top of a large yolk cell. Epiboly involves the coordinated vegetal movement of an epithelial sheet (enveloping layer, EVL), small groups/individual cells (deep cells, DEL) and a syncytium (yolk syncytial layer, YSL) to completely engulf the yolk cell and close the blastopore at the end of gastrulation (Betchaku and Trinkaus, 1978; Trinkaus, 1951; Warga and Kimmel, 1990) . The deep cells, which make up the embryo proper, are covered by the single-cell thick EVL (Betchaku and Trinkaus, 1978; Kimmel et al., 1990) . The EVL margin is tightly attached to the periphery of the YSL (external YSL, E-YSL), which lies at the interface between the yolk mass and overlying deep cells (Betchaku and Trinkaus, 1978; Kimmel and Law, 1985a) . The prevailing model is that the yolk functions as an epiboly motor, driving the vegetal-ward movement of the YSL through the concerted action of the yolk microtubule and actin cytoskeleton (Behrndt et al., 2012; Betchaku and Trinkaus, 1978; Cheng et al., 2004; Solnica-Krezel and Driever, 1994) . By reason of its tight association to the EVL, epiboly of the YSL draws the blastoderm towards the vegetal pole (Betchaku and Trinkaus, 1978; Trinkaus, 1951) .
It has been proposed that modification of the yolk surface also contributes to the motive forces that drive epiboly movements Trinkaus, 1978, 1986; Cheng et al., 2004;  Contents lists available at ScienceDirect Solnica-Krezel and Driever, 1994) . As the blastoderm advances towards the vegetal pole during epiboly, the surface area of the exposed yolk membrane is progressively reduced (Cheng et al., 2004) . In both Fundulus and zebrafish, the yolk membrane is likely recovered by a discrete region of active endocytosis, located just ahead of the advancing blastoderm margin. This phenomenon is readily observed through the rapid uptake of fluorescent fluidphase markers into vesicles (Betchaku and Trinkaus, 1986; SolnicaKrezel and Driever, 1994) . Vesicles labelled in this manner form a thick, circumferential band within the E-YSL, a region where the yolk cell is actin-rich and its membrane is highly ruffled (Betchaku and Trinkaus, 1986; Cheng et al., 2004) . In Fundulus, this pattern of fluid-phase endocytosis is initiated upon the onset of epiboly and is maintained for the duration of epiboly progression (Betchaku and Trinkaus, 1986) . In contrast, in the zebrafish, marginal yolk cell endocytosis has been reported to be restricted to the later, progression phase of epiboly when the bulk of yolk cell membrane is removed (Cheng et al., 2004; Solnica-Krezel and Driever, 1994) .
Although it is generally held that bulk endocytic removal of the yolk cell membrane is required for the normal progression of epiboly in the zebrafish, the functional consequence of inhibiting this process has never been examined. To determine the relative contribution of yolk membrane endocytosis on YSL epiboly, we focused our attention on the large multi-domain GTPase, Dynamin, a component of the endocytic machinery that is common to many mechanisms of endocytosis (Doherty and McMahon, 2009; Ferguson and De Camilli, 2012) .
In mammals, there are three dynamin genes (dnm1-3), with dnm1 expressed in neurons, dnm3 expressed primarily in the brain, lung and testis and dnm2 expressed ubiquitously (Cook et al., 1994; Nakata et al., 1991 Nakata et al., , 1993 Sontag et al., 1994) . Drosophila possess a single dynamin homolog, shibire, which is expressed ubiquitously during early development (Chen et al., 1991 (Chen et al., , 1992 van der Bliek and Meyerowitz, 1991) . Dynamin is best known for its role in coated pit formation and vesicle fission during clathrin-mediated endocytosis (CME) (Damke et al., 2001; Hill et al., 2001; Kosaka and Ikeda, 1983a; Loerke et al., 2009; van der Bliek and Meyerowitz, 1991) . The bulk uptake of plasma membrane and extracellular fluid, however, is predominantly through Clathrin-independent endocytic (CIE) mechanisms, which account for an estimated 40-70% of constitutive fluid-phase internalization depending on the cell type (Cheng et al., 2006; Howes et al., 2010; Sabharanjak et al., 2002; Sandvig et al., 1987) . Whether Dynamin regulates CIE mechanisms and, in particular those that involve the uptake of fluid-phase, is a debated issue as different means of Dynamin inhibition have varying effects depending on the experimental context (Altschuler et al., 1998; Cao et al., 2007; Damke et al., 1994 Damke et al., , 1995 Guha et al., 2003; Herskovits et al., 1993; Kosaka and Ikeda, 1983b; Lundmark et al., 2008; Macia et al., 2006; Sabharanjak et al., 2002) .
Using a combination of drug-and dominant-negative based approaches to inhibit the function of Dynamin in the developing zebrafish embryo, we show that epiboly-affiliated marginal fluidphase endocytosis is a partially Dynamin-dependent process. However, yolk-biased knockdown of Dynamin had little effect on epiboly progression, suggesting Dynamin-dependent endocytic recovery of yolk membrane is dispensable for the successful completion of epiboly. Global means of Dynamin inhibition, on the other hand, did affect epiboly of the blastoderm, suggesting Dynamin regulates epiboly in another manner. We find the epiboly delay induced by Dynamin inhibition is associated with profound morphological and structural defects in the EVL. We present evidence suggesting that Dynamin maintains EVL integrity through the regulation of the ezrin/radixin/moesin (ERM) family of proteins and the small GTPase Rho A.
Results
Dynamin is required for successful completion of epiboly, but Dynamin-dependent fluid-phase endocytosis in the yolk cell is dispensable
We inhibited Dynamin, a large GTPase with a wellcharacterized role in vesicle scission, to test whether its function was required for epiboly initiation and progression. Dynasore is a rapid-acting, cell-permeable, reversible inhibitor of Dynamin GTPase activity which reduces endocytosis by inhibiting vesicle fission (Macia et al., 2006) . Dechorionated embryos were bathed in embryo medium (EM) containing 0.1% DMSO or 75 μM dynasore (dyna) for the duration of epiboly. A strong and consistent delay in epiboly progression was observed in 97% (n ¼ 325) of embryos receiving sustained dynasore treatment from oblong-sphere stage (3.7-4 h post fertilization, hpf) and continuing through the duration of doming and progression (Fig. 1A-C) . The effect on epiboly initiation was subtle and highly variable. Dynasore treated embryos appeared to dome in a timely fashion; however, the blastoderm often did not dome in a uniform manner (Fig. 1C , arrowhead). Epiboly delay was first evident early in the progression phase, with dynasore treated embryos reaching only 30-40% epiboly when controls had reached the 50% mark ( Fig. 1A′-C′) . Epiboly of the deep cells and EVL was consistently delayed in response to Dynamin inhibition, whereas the progression of the YSL was partially affected (Fig. 1D-G) . While the main YSN front was located near the delayed blastoderm margin in dynasore treated embryos, 80% (n¼ 10) of embryos had small clusters of YSN that had escaped the YSN front and had undergone epiboly to approximately the same extent as controls (Fig. 1F, arrowheads) . As indicted by the presence of the embryonic shield, dynasore treated embryos began to gastrulate at the same time as controls, thus the delay was not likely caused by a general developmental delay ( Fig. 1A′ -C′, arrowheads). Prolonged treatment (beyond 60% epiboly) resulted in a high rate of mortality, with the majority of embryos lysing their yolk.
To confirm that the epiboly delay in dynasore treated embryos was specific to inhibiting Dynamin function, we expressed a dominant-negative mutant version of Dynamin 2 (K44A, DNDnm2) which carries a point mutation in its nucleotide binding site, reducing its ability to bind GTP (Damke et al., 1994) . Expression of this construct has been shown to disrupt endogenous Dynamin function and inhibit vesicle scission in other systems. A similar, but less robust, effect was attained when RNA encoding DN-Dnm2 was injected into the yolk at the 1-cell stage. Approximately 66% of embryos globally expressing DN-Dnm2 experienced a delay in epiboly starting in the early progression phase (n ¼169, Fig. 2A -C, E), but embryos managed to successfully complete epiboly. As observed in dynasore treated embryos, epiboly of the deep cells, EVL and YSL was delayed in response to global DNDnm2 expression (n ¼10, Fig. 2F, Supplementary Fig. S1 ).
Next, we tested whether inhibition of Dynamin impeded fluidphase endocytosis in the yolk cell by examining the uptake of a fluorescent fluid-phase marker, FITC, in embryos with compromised Dynamin function. Relative to DMSO control treated embryos, 100% (n ¼20) of dynasore treated embryos had fewer FITC-containing vesicles at the margin ( Fig. 3A and B) . In these embryos, the number of FITC-containing vesicles was reduced by an estimated 62% (Fig. 3E) . Unexpectedly, we observed that fluidphase markers penetrated the EVL and seeped into the deep cell layer of dynasore treated embryos (86%, n ¼29, Fig. 3B, arrow) , suggesting that the barrier function of the EVL epithelium was compromised in response to dynasore treatment. Similarly, 89% of embryos globally expressing DN-Dnm2 showed reduced uptake of our fluid-phase marker (n ¼9, Fig. 3C and D) . On average, global expression of DN-Dnm2 caused 52% reduction in FITC containing vesicles at the margin (Fig. 3F) . Thus, while DN-Dnm2 had a more mild effect on epiboly than dynasore treatment, both means of Dynamin inhibition affected fluid-phase endocytosis at the margin to a similar extent. In addition, we saw that inhibition of Dynamin caused defects in not only the yolk cell, but also the EVL.
These data led us to question whether the epiboly delay caused by Dynamin inhibition was the result of disrupting Dynamindependent fluid-phase endocytosis in the yolk cell or due to defects in the blastoderm. To differentiate between these two possibilities, we biased expression of DN-Dnm2 to the yolk cell and examined its effect on epiboly. To achieve a regionalized knockdown of Dynamin function in the yolk cell, RNA encoding DN-Dnm2 was injected into the yolk at the 16-32 cell stage (1.5-1.75 hpf), after cytoplasmic streaming towards the blastoderm has slowed (Fig. 2E , Supplementary Fig. S1 ). Yolk-biased expression of DN-Dnm2 failed to cause a significant epiboly delay phenotype (13% delayed, n¼179, Fig. 2D, Supplementary Fig. S1 ). Yolk-biased expression of DN-Dnm2 did not significantly disrupt epiboly of the EVL, deep cells or the YSL (Fig. 2G) . To confirm that our strategy of yolk-biased expression of DN-Dnm2 was effectively inhibiting fluid-phase endocytosis, we examined uptake of our fluid-phase marker FITC under these conditions. Indeed, the number of FITC containing vesicles was reduced in 88% of the embryos examined (n¼24, Supplementary  Fig. S1 ), with an average reduction of 48% (Fig. 3F) . Therefore, while yolk-biased expression of DN-Dnm2 can effectively reduce fluidphase endocytosis in the yolk cell to levels comparable to that of global Dynamin inhibition, embryos can undergo normal epiboly. These data suggest that Dynamin-dependent endocytic removal of yolk cell membrane is not required for the proper progression of epiboly. Consistent with these data, we found that the marginal pattern of fluid-phase endocytosis emerges prior to the onset of epiboly and is not restricted to the yolk cell ( Supplementary Fig. S2 ), implying that this phenomenon might serve some purpose other than to drive epiboly movements.
Dynamin is required to support EVL cell morphology and epithelial integrity
Because yolk-biased Dynamin inhibition failed to have any effect on epiboly, we attributed the epiboly delay observed upon global inhibition of Dynamin to defects in the blastoderm. We noted that the barrier function of the EVL was compromised in dynasore treated embryos, as evidenced by the passage of our fluid-phase marker into the deep cell layer. This observation, coupled with recent work highlighting the importance of proper EVL specification and integrity for epiboly (Carreira-Barbosa et al., 2009; Fukazawa et al., 2010; Pei et al., 2007; Sabel et al., 2009; Siddiqui et al., 2010) , prompted us to examine Dynamin's function in the EVL in more detail.
To further characterize this EVL defect, embryos were bathed in EM, DMSO or dynasore, fixed at 60% epiboly and stained for F-actin. Striking defects in EVL cell morphology were revealed by phalloidin staining (Fig. 4A-C) . Most notably, EVL cells became irregular in shape and size in response to dynasore treatment, with rounded cells scattered across the EVL (98%, n ¼ 45, Fig. 4C and C′). In some cases, the rounded cells were observed with actin-based processes below the plane of the EVL, extending into the underlying deep cells (Fig. 4C′, arrowheads) . Actin organization in the marginal EVL cells and in the E-YSL has been shown to be important for late epiboly progression and blastopore closure (Köppen et al., 2006) . However, the marginal actin band at the leading edge of the EVL and the punctate E-YSL actin band were intact in dynasore treated embryos (Fig. 4C, arrowhead) , suggesting Dynamin does not play a significant role in organizing actin in this region. Live time-lapse confocal imaging of dynasore treated embryos expressing membrane-bound GFP (mGFP) revealed that EVL cells lost contact with their neighbours (Fig. 4D , arrows) and were sometimes extruded basally from the epithelium ( Fig. 4D and K, arrowheads). While still maintaining contact basally, apical gaps periodically formed between adjacent membranes, giving the EVL a cobblestone-like appearance ( Fig. 4D and K). Having lost partial contact with neighbouring cells, EVL cells tended to round at their apices and lose their characteristic polygonal shape. Live imaging also revealed that the structural defects in the EVL were transient. EVL cells that had lost contact were occasionally observed re-establishing contact with their neighbours (Fig. 4D , arrows) or gaps were mended with cells from below the plane of the EVL (Fig. 4D, arrowheads) .
As tight junctions are required for the maintenance of barrier function in epithelia (Gumbiner, 1993) , we examined whether the tight junction component ZO-1 was disrupted or mislocalized in dynasore treated embryos. ZO-1 antibody staining was irregular and unevenly distributed around the periphery of EVL cells in the majority of embryos examined (91%, n¼ 35, Fig. 4EÀ G, arrows). While some cells appeared to have the normal distribution of ZO- 1, staining was hardly visible in adjacent cells. In 57% (n ¼35) of the embryos examined, separations between adjacent EVL membranes were observed ( Fig. 4G , arrowheads). The EVL is attached to the YSL membrane by tight junctions, which prevents deep cells from surpassing the EVL margin during epiboly (Köppen et al., 2006) . Consistent with the discontinuous ZO-1 staining observed in the EVL, cells occasionally superseded the EVL margin, as observed in live dynasore treated embryos expressing mRFP ( Fig. 3B , arrowheads). These could be deep cells that have surpassed the EVL margin, suggesting the tight junction EVL-YSL attachment was disrupted. Alternatively, they may be EVL cells that have detached from the epithelium. ERM (ezrin/radixin/moesin) proteins play a structural role in epithelia, providing a physical link between the plasma membrane and cortical cytoskeleton (Bretscher, 1999; Sato et al., 1992) . It has been shown in other systems that the ERM family of proteins is important for cortical actin assembly and the maintenance of epithelial integrity. In Drosophila moesin mutants, the epithelial cells which make up the wing imaginal discs have disorganized cortical actin and are basally extruded from the epithelium (Speck et al., 2003) . These defects were reminiscent of those observed in the EVL of dynasore treated embryos, therefore, we examined them for changes in activated ERM. Phosphorylated ERM (P-ERM) was detected at the periphery of EVL cells, co-localizing with the cortical actin belt, in untreated and DMSO treated controls ( Fig. 4H and I ). In contrast, membrane localization of P-ERM was severely disrupted in 90% of embryos treated with dynasore (n¼21, Fig. 4J ). Little to no P-ERM co-localized with the cortical actin belt in dynasore treated embryos and 95% (n¼21) of embryos examined had scattered EVL cells with an apical membrane enrichment of P-ERM (Fig. 4J′, arrowheads) . Similar morphological defects were observed when we mosaically expressed DN-Dnm2 within the EVL. We injected plasmids encoding UAS-gfp-CAAX or UAS-zdnm2-like-k44a-gfp-CAAX, into transgenic embryos which conditionally express the optimized Gal4 KalTA4 under the control of a keratin 18 (krt18) promoter, driving EVL expression of gfp alone or the separate expression of gfp and dn-dnm2l from a bidirectional promoter. Because the EVL contributes cells to the deep cell layer up until late blastula stages (Kimmel and Law, 1985b) , we induced the expression of KalTA4 with tamoxifen at 30% epiboly to generate small clones of mostly EVL cells that express GFP or GFP and DN-Dnm2. Note that while induction with tamoxifen at 30% epiboly minimizes the number of GFP-labelled deep cells, some deep cell labelling is still observed ( Fig. 5A′ and B′, arrowheads). Embryos were fixed at 60-90% epiboly (7-9 hpf), stained with rhodamine phalloidin and examined for defects in EVL cell morphology ( Fig. 5A and B) . The effects of EVL-biased DN-Dnm2 expression were mild in comparison to those caused by dynasore treatment; however, distorted EVL cell morphology was evident in phalloidin stained embryos (100%, n¼ 24 embryos, Fig. 5B ). The apical surface area of EVL cells expressing DN-Dnm2 was, on average, smaller than that of cells which expressed GFP alone (Fig. 5C ). EVL cells in control injected embryos made contact with an average of 6.0 neighbouring cells, along their edges (n ¼ 130 cells, Fig. 5D ). The irregular cell morphology of DN-Dnm2 expressing cells, however, increased this average to 6.3 contacts per cell, with cells meeting not only along their edges, but also at their vertices (n ¼211 cells, Fig. 5B″ , arrow, C). The irregularity in cell size and non-optimal cell packing gave the EVL a disorganized appearance. In addition, ZO-1 antibody staining was reduced or discontinuous in 68% of cells expressing DN-Dmn2 (n ¼41 cells, Fig. 5E and F) . Despite the defects in EVL cell morphology and ZO-1 distribution, epiboly proceeded in a timely manner. The comparatively mild phenotype is likely due to the limited size and distribution of DN-Dnm2 expressing clones and/or the shortened timeframe in which Dynamin function was disrupted.
Dynamin is required for the proper localization of adherens junction components
From our live imaging of dynasore treated embryos, we noted that adjacent EVL cells transiently lost contact apically, while maintaining contact basally. As adherens junctions (AJ) mediate the intercellular adhesion within an epithelium and are localized sub-apically, we suspected that the AJ were disrupted in the EVL of dynasore treated embryos. We bathed embryos expressing membrane-bound GFP (mGFP) in EM, DMSO or dynasore and stained for F-actin, β-Catenin and pan-Cadherin. Stained embryos were subsequently imaged from the animal pole by confocal microscopy (Figs. 4A′À C′, 6 ). F-actin and the components of the AJ junction complex are normally localized to the periphery of each cell in the EVL in untreated and control treated embryos (Figs. 4A′ and B′, 6A, B, D and E). We anticipated that staining for AJ components would be reduced or absent at the intercellular junctions, similar to what we observed with ZO-1 staining. While we did observe some regions of the EVL devoid of junctional staining (Fig. 6F) , we regularly detected enhanced staining for F-actin, β-Catenin and Cadherin at the periphery of EVL cells in dynasore treated embryos (Figs. 4C′, 6C and F) .
We rotated our Z-stack images to visualize the localization of these markers with respect to the apical-basal axis (Fig. 4A′À C′ below XY projections, 6A′ À F′). Phalloidin stains the F-actin-rich microvilli which cover the apical surface of the EVL as well as the cortical actin belt (Fig. 4A′ and B′) . While phalloidin staining was observed in its normal location on the apical surface and at the periphery of EVL cells in dynasore treated embryos, ectopic F-actin was also detected in the basal-most region of rounded EVL cells (Fig. 4C′) . β-Catenin, which is normally localized to basal-lateral membrane and intercellular junction of EVL cells (Fig. 6A′ and B′) , was expanded basally, along the entire length of the lateral membrane in response to Dynamin inhibition (100%, n ¼23, Fig. 6C′, arrowhead) . Cadherins normally co-localize with β-Catenin at EVL cell junctions and the basal À lateral membrane ( Fig. 6D′ and E′) . Junctional pan-Cadherin antibody staining was expanded in a manner comparable to β-Catenin staining (82%, n ¼11 embryos, Fig. 6F′, arrowhead) . Together these data show that the proper positioning of the cortical actin belt, β-Catenin and Cadherin along the apical and basal axis depends on Dynamin function.
Concomitant with a basal-ward shift in the position of AJ markers, we observed an expansion of apical membrane. aPKC, which marks the apical surface of the EVL in untreated and control treated embryos, was found to be expanded basally in response to dynasore treatment (100%, n ¼ 11, Fig. 6G′ À I′, arrowhead) . In EVL cells rounded by dynasore treatment, aPKC staining was observed on the lateral membrane between adjacent cells. aPKC staining also revealed that the apical membrane is highly folded in embryos treated with dynasore, particularly the apical membranes of the most distorted cells (100%, n ¼11, Fig. 6I, arrows) . This correlates with a potential reduction in tension across the EVL, which is likely the result of integrity issues discussed above.
Dynasore-induced EVL defects are not a result of failed differentiation or apoptosis
Zebrafish poky/chuk/ikk1 mutants fail to differentiate the EVL, do not maintain a permeability barrier and also have delayed epiboly (Fukazawa et al., 2010) . To determine whether the EVL properly differentiates in dynasore treated embryos, we treated embryos from oblong-sphere stage until 75% epiboly and performed whole-mount in situ hybridization for the epithelial differentiation marker, keratin 4 (krt4, Fig. 7A-C) . krt4 expression was only mildly affected by Dynamin inhibition, with 64% of embryos displaying small patches with reduced staining (n ¼92, Fig. 7C, arrowheads) . Under our standard treatment paradigm, we placed embryos in dynasore prior to sphere stage when the EVL becomes lineage restricted and fully differentiated (Kimmel and Law, 1985b) . Next, we asked whether EVL cells fail to differentiate in the presence of dynasore or whether EVL cells failed to maintain their EVL fate. We treated embryos with dynasore at 40% epiboly, after the EVL is differentiated, fixed them at 90% epiboly and stained them for krt4. Similar to embryos treated under our standard paradigm, krt4 expression was mildly reduced in a patchy manner in embryos treated with dynasore at 40% epiboly (100%, n ¼20, data not shown). Embryos treated with dynasore at 40% epiboly showed the same defects in EVL cell morphology as those observed with earlier treatment and also delayed epiboly (data not shown). Taken together, these results suggest that the EVL defects observed upon dynasore treatment are not caused by a widespread failure to differentiate the EVL. Instead, some EVL cells fail to maintain their epithelial identity in the presence of Dynamin inhibition, which may be a secondary effect of losing epithelial integrity.
Loss of epithelial identity, disrupted polarity and cell extrusion can occur when epithelial cells undergo cell death (Eisenhoffer and Rosenblatt, 2011; Wang et al., 2011) . To determine whether krt4-positive EVL cells were eliminated from the epithelium due to apoptosis, dynasore treated embryos were stained with both phalloidin and anti-cleaved Caspase 3 (Fig. 7D-F) . Apoptotic cell death was not widespread in dynasore treated embryos. Few Caspase 3-positive cells were found in dynasore treated embryos (1-5 cells in 88%, n ¼8, Fig. 7F ) and none of these cells were incorporated in the EVL (n ¼17 cells, Fig. 7F inset) , suggesting they become apoptotic after they have been extruded from the epithelium. Constricting cells had intact nuclei (Fig. 8K, arrowhead) , further suggesting that constricted cells were not undergoing cell death prior to extrusion. This is reminiscent of a stochastic, live cell extrusion mechanism used to maintain optimal cell packing in the Drosophila notum epithelium (Marinari et al., 2012) .
Dynamin maintains EVL integrity through the regulation of Rho A activity
The most striking defect observed in dynasore treated embryos was a loss of EVL integrity, accompanied by a reduction of cortical activated ERM. Although we were able to phenocopy the EVL and epiboly defects associated with Dynamin inhibition by injecting a previously published morpholino (MO) directed against ezrin2 (Link et al., 2006; Schepis et al., 2012) , we were not able to rescue the effects of dynasore treatment by ezrin2 over-expression ( Supplementary Fig. S3 ). We attribute this to an over-expression phenotype in ezrin2 injected embryos that closely resembled that of dynasore treatment.
Antagonizing Rho function can rescue the integrity of the wing imaginal disc epithelium in Drosophila moesin mutants (Speck et al., 2003) . In addition, defects in cell morphology in the intestinal epithelium of mouse ezrin mutants were associated with increased Rho activity (Casaletto et al., 2011) . Thus, to circumvent the issues associated with ezrin2 over-expression, we shifted our focus to the small GTPase Rho A. We attempted to rescue the dynasore phenotype by antagonizing Rho A function. Embryos were injected at the 1-cell stage with RNA encoding H2A mCherry alone (cntl inj, nuclear localized) or H2A mCherry and DN-Rho A (dn-rho) and then treated with EM, DMSO or dynasore (Fig. 8) . Control injected embryos treated with dynasore showed the typical epiboly delay (Fig. 8C and M) and EVL defects ( Fig. 8G and K) characteristic of dynasore treatment. Embryos that were co-injected with RNA encoding DN-Rho, on the other hand, showed a significant improvement in both epiboly progression ( Fig. 8D and M) and EVL cell morphology (83%, n ¼18, Fig. 8H and L).
Rho has been implicated as a negative regulator of endocytosis in other contexts (Lamaze et al., 1996) . To determine whether DNRho restored epiboly in dynasore treated embryos by restoring endocytosis at the margin, we examined the uptake of fluid-phase in DMSO and dynasore treated embryos expressing DN-Rho (Fig. 3E) . DN-Rho did not significantly affect fluid-phase endocytosis under control treatment conditions (n¼ 17, Fig. 3E ). Embryos expressing DN-Rho and treated with dynasore have a 50% reduction in vesicles relative to control injected DMSO controls (n ¼16). This reduction in endocytosis was not statistically significant from the 62% reduction observed in control injected embryos treated with dynasore (n ¼20), suggesting that DN-Rho is not mediating its rescue effect by restoring marginal fluid-phase endocytosis. These data also provide additional evidence that endocytic removal of the yolk membrane is dispensable for epiboly progression, as dynasore treated embryos rescued by expression of DN-Rho undergo epiboly normally despite having reduced marginal endocytosis.
Discussion

Dynamin is a key regulator of marginal fluid-phase endocytosis
Since the first description of fluid-phase endocytosis at the margin in the related teleost fish Fundulus, we have learned little about the molecular underpinnings controlling this process. From the original studies in Fundulus and more recent work in zebrafish, we know that marginal endocytosis occurs in the E-YSL, a region where the yolk cell membrane is highly ruffled (Betchaku and Trinkaus, 1986; Cheng et al., 2004) . In Fundulus, uncoated rod-shaped vesicles are predicted to form from the fusion of adjacent membrane ruffles in the E-YSL (Betchaku and Trinkaus, 1986) . In the zebrafish, the region of marginal endocytosis overlaps with the punctate actin band in the E-YSL (Cheng et al., 2004) , but whether the punctate actin band may be involved in regulating this process has not been tested. Here we identify Dynamin as the first component of the molecular machinery to be implicated in regulating the constitutive fluid-phase endocytosis that occurs at the blastoderm margin throughout epiboly.
Although Dynamin has a well-defined role in vesicle formation and fission in CME, studies aiming to elucidate Dynamin's role in fluid-phase endocytosis have garnered inconsistent results. Using both drug-based (dynasore) and dominant-negative (Dnm K44A) approaches, we show that inhibition of Dynamin can reduce fluidphase uptake at the blastoderm margin by 62% and 52%, respectively. These data are in accordance with the 60% reduction in fluid-phase uptake observed in cultured BSC-1 cells treated with dynasore (Macia et al., 2006) and the work by Cao et al. (2007) showing constitutive fluid-phase endocytosis in epithelial cells is reduced by 50-60% when microinjected with inhibitory Dynamin antibodies or reduced by 70% when treated with siRNA directed against dnm2. Thus, based on these studies in cultured cells, an estimated 50-70% of constitutive fluid-phase endocytosis occurs in a Dynamin-dependent manner and our data support that estimate in an in vivo context. Notably, we found that DN-Dnm2 (K44A) was nearly as effective at reducing fluid-phase endocytosis as treatment with the small molecule inhibitor dynasore. This is in stark contrast to previous studies showing the Dnm K44A mutation to be ineffective in blocking fluidphase endocytosis in other contexts (Altschuler et al., 1998; Damke et al., 1994; Herskovits et al., 1993) . Cao et al. (2007) showed that high serum conditions, under which cells are typically cultured, attenuated the effect of Dynamin inhibition on fluid-phase endocytosis. The attenuated effect is likely caused by the presence of growth factors which are known to stimulate macropinocytic uptake of fluid-phase markers (Haigler et al., 1979; Liu et al., 2008; Racoosin and Swanson, 1989 ). An advantage of our system is that the embryo medium in which we grow our zebrafish embryos is serum-and growth factorfree, thus eliminating a source of error which would underestimate the proportion of fluid-phase endocytosis that occurs in a Dynamindependent manner. This feature, coupled with the abundance of genetic and molecular tools available for use in the zebrafish, makes this system as an attractive in vivo model for future study of the molecular mechanisms that regulate the different endocytic pathways.
Dynamin function is essential for epiboly of the zebrafish blastoderm, but Dynamin-dependent endocytosis in the YSL is dispensable It is hypothesized that bulk endocytic removal of yolk cell membrane ahead of the blastoderm margin during epiboly is required to reduce the surface area of exposed yolk cell and may help drive epiboly movements by exerting a pulling force on the blastoderm (Betchaku and Trinkaus, 1986; Cheng et al., 2004; Kane and Adams, 2002; Solnica-Krezel and Driever, 1994) . In zebrafish, evidence suggesting yolk cell endocytosis might play a role in driving epiboly movements came from work where destruction of the yolk microtubule network slowed, but did not completely arrest epiboly of the EVL (Solnica-Krezel and Driever, 1994) . EVL epiboly in this scenario was attributed to marginal endocytosis, which occurred normally in these embryos. Our finding that approximately 60% of endocytosis in the yolk was Dynamindependent allowed us, for the first time, to directly test whether this phenomenon was necessary for the proper progression of epiboly.
We found Dynamin to be required for the successful progression of epiboly, but not in the manner in which we expected. Global inhibition of Dynamin using the inhibitor dynasore reduced endocytosis within the yolk; however, the YSL epiboly was only partially affected. Moreover, dynasore treatment had a more severe impact on epiboly than DN-Dnm2 expression, yet both means of Dynamin inhibition disrupted marginal fluid-phase uptake to a similar extent, raising the possibility that this was not the underlying cause of the epiboly delay. Consistent with these data, yolk-biased knockdown of Dynamin function effectively reduced fluid-phase endocytosis in the yolk cell, but failed to affect epiboly progression of the blastoderm. Additionally, expression of DN-Rho restored normal epiboly in dynasore treated embryos without restoring endocytosis at the margin. Therefore, the Dynamin-dependent fraction of fluid-phase endocytosis at the margin is dispensable for epiboly progression.
Because Dynamin inhibition did not completely eliminate fluidphase endocytosis in the yolk cell, we cannot definitively say that this phenomenon plays no role in epiboly. It is possible that the residual endocytosis in embryos with yolk-biased DN-Dnm2 or in those rescued with DN-Rho is sufficient to drive epiboly movements or that other, small volume endocytic processes might compensate for the loss of high volume endocytosis at the margin. However, our data fits with a recent model proposing that dynamics of the actomyosin ring in the E-YSL generates all the force necessary to drive EVL epiboly (Behrndt et al., 2012) . The model predicts that the force driving epiboly of the EVL is generated by a combination of friction resisted actomyosin flow and circumferential actomyosin contraction within the E-YSL. The combined force predicted to be generated by these two mechanisms matched with measured animal-vegetal tension within the embryo. Thus, this model would suggest that endocytosis of yolk membrane need not contribute any additional force for epiboly of the EVL.
Dynamin maintains EVL cell morphology and integrity during epiboly
Inhibition of Dynamin was associated with defects in EVL cell morphology and integrity. Treatment with dynasore caused scattered cells within the EVL to adopt a rounded morphology. Live imaging showed that this was a result of adjacent cells in the EVL periodically losing contact at their apices and, on occasion, rounded cells were basally extruded from the epithelium. The barrier function of the EVL was compromised in response to dynasore treatment, allowing the passage of fluid-phase markers into the deep cell layer. The increase in EVL permeability was correlated with discontinuity in the distribution of the tight junction component ZO-1 and the separation of adjacent cell membranes at the level of the tight junction.
We propose that Dynamin-dependent maintenance of EVL integrity is required for normal epiboly progression. When we disrupted the EVL by dynasore treatment, DN-Dnm2 expression or ezrin knockdown, we observed a correlating delay in epiboly.
Furthermore, DN-Rho rescued the dynasore associated EVL defects and also restored epiboly. These data fit with a growing body of evidence showing that the integrity and differentiation of the EVL is essential for normal epiboly (Carreira-Barbosa et al., 2009; Fukazawa et al., 2010; Pei et al., 2007; Sabel et al., 2009; Siddiqui et al., 2010) . While embryos treated with dynasore had minor problems maintaining a fully differentiated EVL, the reduction in keratin gene expression was mild in comparison to poky mutants, foxh1 morphants and embryos expressing DN-irf6 which all have a widespread failure in EVL differentiation (Pei et al., 2007; Sabel et al., 2009 ). Thus, we attribute the epiboly delay to problems in EVL integrity rather than differentiation.
Although we saw a strong correlation between an epiboly delay and defects in the EVL, we were not able to exclude the possibility that defects in the deep cells also contribute to the epiboly phenotype in dynasore treated embryos. We attempted to address this issue by biasing expression of DN-Dnm2 in the EVL using the krt18-kalT4A transgenic line. The limited size and distribution of DN-Dnm2 expressing clones and late induction of DN-Dnm2 expression hindered our ability to delineate the relative contributions of the EVL and deep cells to the epiboly phenotype. Currently, there is no method to broadly manipulate gene expression specifically in the EVL at early epiboly stages and we look forward to the development new tools to do so.
Dynamin regulates EVL integrity by supporting ERM protein function and antagonizing Rho activity
The most notable defect in dynasore treated embryos was the absence of activated ERM localized to the cortex of EVL cells, suggesting that Dynamin might be regulating EVL integrity through promoting ERM activity and/or localization. Consistent with this prediction, we showed that morpholino knockdown of ezrin2 in the zebrafish closely phenocopied the effects of Dynamin inhibition. Our data are in agreement with evidence from other systems which demonstrate that ERM protein function is crucial for the maintenance of epithelial cell morphology and integrity (Casaletto et al., 2011; Pilot et al., 2006; Saotome et al., 2004; Speck et al., 2003) . In these systems, the absence/reduction of ERM function is associated with defects in actin organization, disruptions in apical À basal polarity and, in the case of the wing imaginal disc of Drosophila moesin mutants, basal extrusion of cells from the epithelium.
A fundamental role Dynamin plays in the regulation of EVL integrity and epiboly appears to be to antagonize Rho activity. This is evidenced by the successful rescue of the epiboly and EVL phenotype of dynasore treated embryos by expression of DN-Rho. Dynamin may be antagonizing Rho activity directly, or possibly indirectly through the regulation of ERM. The morphological defects observed in intestinal epithelium of mouse ezrin mutants were associated with an increase in Rho activity (Casaletto et al., 2011) . Likewise, Moesin antagonizes Rho activity to maintain epithelial integrity in the wing imaginal disc in Drosophila (Speck et al., 2003) . We have taken several approaches to attempt to show that Rho activity is elevated in embryos with compromised Dynamin function, but we were unable to detect any change (data not shown). In future work, we hope to further characterize the relationship between Dynamin, Rho and ERM in our system.
A model for Dynamin-dependent maintenance of EVL integrity during epiboly
We present our model for Dynamin-dependent maintenance of EVL integrity in Fig. 9 . The forces which drive epiboly of the EVL arise in the E-YSL, where a combination of friction-resisted actomyosin flow towards the animal pole and circumferential actomyosin contraction contribute to its vegetal movement (Behrndt et al., 2012 ). An essential component of this model is that the EVL must be mechanically coupled to the actomyosin ring within the E-YSL. This is thought to be mediated by tight junctions (Köppen et al., 2006) , which transmit the forces generated in E-YSL to the EVL. These vegetal-ward forces pull the EVL taut, progressively stretching and flattening the cells, forming a squamous surface epithelium (Kimmel et al., 1995; Sagerström et al., 2005) . Inhibition of Dynamin disrupts the generation and transmission of tension across the epithelium, leading to abnormal and distorted cell morphologies within the EVL and impaired epiboly. Dynasore treatment interrupts the tight connection between the EVL and YSL, as evidenced by irregularities in ZO-1 staining and the occasional movement of deep cells past this connection. Furthermore, live imaging reveals that the apical connection between EVL cells was transiently disrupted, causing individual cells to round or stretch as they lose and regain contact with their neighbours.
The cortical cytoskeletons of neighboring cells are mechanically coupled via the adherens junction, allowing for the transmission of forces between cells within an epithelium (Martin et al., 2010) . Inhibition of Dynamin cause both discontinuity and mislocalization of the adherens junction components β-Catenin and Cadherin. We speculate that the asymmetrical localization of adherens junction components and actin in adjacent cells may lead to inefficient coupling and, subsequently, generates defects in EVL cell morphology. Lending support to this model, it was recently reported that a subset of cells in the Drosophila embryo undergoes a Myosin II-independent apical constriction, driving the formation of the dorsal folds during gastrulation (Wang et al., 2012) . Adherens junction components shift basally in cells just prior to their constriction, providing an asymmetry in junction localization between neighboring cells. This asymmetry was found to be necessary to drive cell shape changes and subsequent morphogenesis of the epithelium.
We propose that the defects in adherens junction continuity and localization that arise from Dynamin inhibition are, at least in part, caused by the deficiency of activated ERM at the periphery of EVL cells. As in other epithelia where ERM proteins are absent or mislocalized (Casaletto et al., 2011; Pilot et al., 2006) , we observed a correlating basal spread of adherens junction components in the EVL of embryos treated with dynasore. Notably, these tissues also displayed defects in cell morphology and integrity, reminiscent of those induced by Dynamin inhibition. In addition, we found that expression of DN-Rho was capable of restoring cell morphology and integrity of the EVL in embryos treated with dynasore.
How Dynamin regulates ERM activity/localization and antagonizes Rho activity remains an open question. Here, we offer two possibilities. The first relates to Dynamin's well-defined role in vesicle scission during endocytosis. Similar to what is observed in the maintenance of stable adherens junctions (Georgiou et al., 2008; Langevin et al., 2005) , a Dynamin-dependent endocytic pathway might regulate level and localization of activated ERM at the cortex by regulating its recycling. Inhibition of Dynamindependent endocytosis may lead to the accumulation of ERM, or a factor which regulates its activity, in ectopic regions of the cell cortex and deplete the pool of protein available to be recycled back to the intercellular junction. If Dynamin regulates EVL integrity through an endocytosis-based mechanism, however, it is unlikely that the endocytic route is CME since inhibition of CME had a relatively mild impact on EVL morphology (SEL unpublished data).
The second mechanism of Dynamin action we propose relates to its actin organizing function. Recent work has shown that Dynamin can directly bind and regulate the actin cytoskeleton by promoting the uncapping of barbed ends by gelsolin. In addition, Dynamin directly interacts with the SH3 domaincontaining Cortactin, a factor which stabilizes newly formed actin branches and interacts with N-WASP to promote Arp2/3-dependent actin nucleation (Martinez-Quiles et al., 2004; Mooren et al., 2009; Weaver et al., 2002) . Inhibition of Dynamin function may disrupt the balance between branched and unbranched actin, which has been shown to be important in the maintenance of other epithelia (Georgiou et al., 2008; Hudson and Cooley, 2002; Janody and Treisman, 2006; Jezowska et al., 2011) . This balance may be required for the maintenance of active ERM at the cell cortex (Bachman and McClay, 1995; Woodward and Crouch, 2001) or might be required for efficient vesicle scission (Georgiou et al., 2008; Hudson and Cooley, 2002) . In this scenario, DN-Rho would rescue the effect of Dynamin inhibiton by restoring this balance. Moving forward, we hope to further elucidate the mechanism through which Dynamin regulates ERM and Rho activity to promote epithelial integrity within the EVL.
Materials and methods
Zebrafish
Zebrafish embryos were obtained from natural matings of wildtype AB strain fish or transgenic krt18:KalTA4-ERT2 fish. We generated a conditional EVL-specific Gal4 driver line, krt18: KalTA4-ERT2, in which a fusion of the zebrafish-optimized Gal4 and the tamoxifen-binding domain (ERT2) is driven by a keratin 18 promoter (MT, a manuscript submitted elsewhere). Embryos were raised in embryo medium at 28 1C and staged according to Kimmel et al. (1995) .
Fluid-phase endocytosis and vesicle quantification
Manually dechorionated embryos were injected with RNA encoding membrane-bound RFP (mRFP) at 1-cell stage, bathed in FITC for 30 min at the stage indicated, and imaged live at the margin by confocal microscopy. For each image/embryo (n), vesicles were manually counted from confocal Z-stacks using the point tool in Volocity (Perkin Elmer). From each image, the number of FITC-containing vesicles localized to YSL versus the maginal EVL (first 3 tiers of cells) was counted. The number of vesicles localized to the EVL or YSL was expressed as a percentage of the total number of vesicles counted in an image/embryo and these values were averaged to generate the mean percentage of total vesicles residing in the EVL versus YSL. Inhibitor treated embryos and those expressing DN-Dyn2 or DN-Rho were placed in FITC at approximately 40% epiboly and imaged between 40 and 50% epiboly. The total number of marginal, FITC-containing vesicles was quantified from maximum projections of Z-stack images. The data were analysed with two-way ANOVAs with treatment and day as the independent factors using JMP version 9. To meet the assumptions of ANOVA, raw vesicle counts were transformed by taking the square-root. The treatmentnday interactions were not significant so they were not included in final analyses. The least squares means (mean vesicle numbers adjusted for the effect of day) were plotted.
Inhibitor treatments
Dechorionated embryos were bathed in embryo medium alone, embryo medium containing 0.1% DMSO or embryo medium containing 75 μM Dynasore. Dynasore (Sigma) was dissolved in DMSO and subsequently diluted such that the final working solution contained 0.1% DMSO. Unless otherwise specified, embryos were bathed in their respective treatments starting at oblong-sphere stage (3.75 hpf) until they were imaged or fixed at the stage indicated.
DNA constructs, RNA and morpholinos
To generate rat dn-dnm2 RNA, pcDNA3.1(-)HA-Dnm2 K44A (ATCC, MBA-95) was linearized with HindIII and mRNA was in vitro transcribed from T7. Human dn-rho RNA was transcribed from pCS2þ -Rho A-N19 linearized with XhoI, using T3 polymerase. mRNA encoding membrane-bound RFP (mRFP), membranebound GFP (mGFP) or nuclear localized mCherry (H2A mCherry) were transcribed from SP6, using pCS2 þ-mrfp, -mgfp or -H2Amcherry linearized by NotI as template. All mRNAs were in vitro transcribed using the T7/T3/SP6 mMESSAGE mMACHINE kit (Ambion) and were purified using the Ambion MEGAclear kit. The ezrin2 MO (GeneTools) was as described in Link et al. (2006) and Schepis et al. (2012) .
Microinjection
For global expression of DN-Dnm2, DN-Rho, mRFP and/or H2A mCherry, mRNA was microinjected into the yolk cell of embryos at the 1-cell stage as previously described (Bruce et al., 2003) . Yolkbiased expression of DN-Dnm2 was achieved by microinjecting mRNA into the yolk cell at 16-to 32-cell stage. Estimated doses of injected mRNA/MO are as follows: dn-dnm2 (340 pg), dn-rho (260 pg), ezrinMO (8 ng).
Mosaic expression in the EVL
The full-length coding sequence of zebrafish dnm2-like-k44a (dn-dnm2l) (gift from T. Ogura) was blunt end cloned into the EcoRV site of pBR-Tol2-UAS-double-GFP-CAAX, a modified version of the bi-directional UAS system (Distel et al., 2010) . Empty vector (cntl inj) or vector containing dn-dnm2l was injected directly into the blastoderm of embryos obtained from transgenic krt18: KalTA4-ERT2 fish at the 1-cell stage, along with tol2 RNA. Embryos were bathed in 0.5 mM Z-4-hydroxytamoxifen (Sigma H7904: a stock of 5 mM in ethanol) starting at 30% epiboly.
Time-lapse imaging
Embryos were injected at the 1-cell stage with RNA encoding mGFP and treated with dynasore as described above. At dome stage, embryos were mounted in coverslip bottomed dishes (MatTek) in 0.4% low melt agarose containing 75 μm dynasore. Confocal Z-stack images were taken from the animal pole, at 4 min intervals. Still XY frames were taken from a single plane in the sub-apical region. Stacks were rotated into the XZ plane to visualize basal extrusion. Analysis of time-lapse movies was conducted using Volocity software.
Whole-mount immunostaining and in situ hybridization
Dechorionated embryos at the indicated stages were fixed in 4% paraformaldehyde or formaldehyde overnight at 4 1C. Embryos were washed in 0.1% Triton-X in PBS (PBT), permeablized in 0.8% PBT for 1 h at room temperature, then blocked at room temperature for 2-5 h in 5-10% normal goat serum/1% DMSO/0.5-5% Triton-X/PBS. Embryos were incubated in primary antibodies and/or phalloidin diluted in block solution overnight at 4 1C and secondary antibodies at room temperature for 3 h, then mounted in ProLong Gold Antifade (Invitrogen) or Antifade with DAPI for imaging. Dilutions were as follows: Phalloidin Alexa488 (Invitrogen, 1:200), anti-aPKC (Santa Cruz, 1:200), anti-β-Catenin (Sigma, 1:200), anti-pan-Cadherin (Abcam, 1:1000), anti-cleaved Caspase 3 (Cell Signaling, 1:100), anti-P-ERM (Cell Signaling, 1:25), anti-ZO-1 (Invitrogen, 1:200). Secondary antibodies used were as follows: goat-anti-mouse Alexa488 (Invitrogen, 1:500) and goat-anti-rabbit Cy3 (Jackson ImmunoResearch, 1:500). Sytox staining was performed by diluting sytox green (Invitrogen) to a final concentration of 0.5 μM to the fixative. Whole-mount in situ hybridization for keratin 4 was carried out as described by Jowett and Lettice (1994) . Probe was generated by linearizing pBS( þ )-keratin 4 with Not I and in vitro transcribing from T7.
